Cowen And Company, LLC Insmed Inc Call Options Transaction History

Cowen And Company, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$20.42 - $28.13 $181,738 - $250,357	-8,900 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$25.89 - $33.45 $230,421 - $297,705	8,900 New	8,900 $3,000
Q1 2021 May 04, 2021	SELL	$32.28 - $44.3 $274,380 - $376,550	-8,500 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$31.45 - $40.54 $267,325 - $344,590	8,500 New	8,500 $47,000

447

170M

5.79M

5.18M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.82B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.